The Stock2Me Podcast

Stock2Me’s latest podcast features Brent Bedford, President, Chairman & CEO of Perpetual Industries Inc. (OTC: PRPI).

During the interview, Bedford provided an introduction to Perpetual Industries’ business model and how the company is working to minimize the hurdles that can stand in the way of innovation.

“Perpetual Industries really came out of an idea of innovation, helping all these great minds that we have in the world coming up with all these innovative great ideas [by] acting sort of like an incubator or a conduit to allow those ideas to be developed, researched and, ultimately, commercialized,” Bedford explained.

Stock2Me’s latest podcast features Brent Bedford, President, Chairman & CEO of Perpetual Industries Inc. (OTC: PRPI).

During the interview, Bedford provided an introduction to Perpetual Industries’ business model and how the company is working to minimize the hurdles that can stand in the way of innovation.

“Perpetual Industries really came out of an idea of innovation, helping all these great minds that we have in the world coming up with all these innovative great ideas [by] acting sort of like an incubator or a conduit to allow those ideas to be developed, researched and, ultimately, commercialized,” Bedford explained.

Stock2Me’s latest podcast features Brendan Cahill, President & CEO of Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2).

During the interview, Cahill provided an introduction to Excellon’s business model and its current portfolio of production and exploration resource projects spanning North America and Europe.

“Excellon’s actually been around quite a long time. It was founded in 1989 but got to Mexico in the late ‘90s and started the Platosa Mine in 2005. It’s Mexico’s highest-grade silver producer,” Cahill explained. “We produce silver, lead and zinc and sell it into the global market, but Excellon’s always had a big focus on exploration. So, we’re also expanding in Idaho on gold projects and the very fascinating Silver City Project in Saxony, Germany – an area that was mined for 800 years for high-grade silver, with mining only stopping when Germany moved off the silver standard in 1873. We’re the first ones ever to use modern exploration technology on that project, and exploration starts again within the month looking for high-grade silver deposits.”

Stock2Me’s latest podcast features Brendan Cahill, President & CEO of Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2).

During the interview, Cahill provided an introduction to Excellon’s business model and its current portfolio of production and exploration resource projects spanning North America and Europe.

“Excellon’s actually been around quite a long time. It was founded in 1989 but got to Mexico in the late ‘90s and started the Platosa Mine in 2005. It’s Mexico’s highest-grade silver producer,” Cahill explained. “We produce silver, lead and zinc and sell it into the global market, but Excellon’s always had a big focus on exploration. So, we’re also expanding in Idaho on gold projects and the very fascinating Silver City Project in Saxony, Germany – an area that was mined for 800 years for high-grade silver, with mining only stopping when Germany moved off the silver standard in 1873. We’re the first ones ever to use modern exploration technology on that project, and exploration starts again within the month looking for high-grade silver deposits.”

Stock2Me’s latest podcast features Allan Jones, President of Emaginos Inc.

During the interview, Jones discussed the company’s business model and its vision of leveraging proven best practices to transform public school students from passive listeners into active learners.

“We’re a company that’s dedicated to transforming public education. We have this vision of unleashing America’s greatest natural resource – the minds of our children,” Jones said. “A teachable moment occurs when the student wants to learn what the teacher wants to teach. Good teachers can recognize those and take advantage of them; great teachers can create them. What we try to do is put a situation in place that all teachers can become great teachers. We’re focused on kids becoming good learners more than on the content that they learn.”

Stock2Me’s latest podcast features Allan Jones, President of Emaginos Inc.

During the interview, Jones discussed the company’s business model and its vision of leveraging proven best practices to transform public school students from passive listeners into active learners.

“We’re a company that’s dedicated to transforming public education. We have this vision of unleashing America’s greatest natural resource – the minds of our children,” Jones said. “A teachable moment occurs when the student wants to learn what the teacher wants to teach. Good teachers can recognize those and take advantage of them; great teachers can create them. What we try to do is put a situation in place that all teachers can become great teachers. We’re focused on kids becoming good learners more than on the content that they learn.”

Stock2Me’s latest podcast features Paul Duffy, President of Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF).

During the interview, Duffy explains how the company’s technology uses your smartphone to “augment” your view by superimposing a hologram into your physical location.

“What makes us different is that we put augmented reality into everything that we do. AR is the ability to take photorealistic objects – it could be people, products or places – and superimpose them using your smartphone,” Duffy said. “So, as you view your phone over a location you can conjure up a hologram and literally augment the reality of that space. If you want to view a vacuum cleaner, you could literally press a button on our website, and it will conjure up through your browser that particular vacuum as a hologram. You can pinch it, zoom it, rotate it, put it in your closet and take a selfie to send to your partner and say, ‘That’s the one we want to buy.’ AR is very useful in converting online shoppers into buyers.”

Stock2Me’s latest podcast features Paul Duffy, President of Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF).

During the interview, Duffy explains how the company’s technology uses your smartphone to “augment” your view by superimposing a hologram into your physical location.

“What makes us different is that we put augmented reality into everything that we do. AR is the ability to take photorealistic objects – it could be people, products or places – and superimpose them using your smartphone,” Duffy said. “So, as you view your phone over a location you can conjure up a hologram and literally augment the reality of that space. If you want to view a vacuum cleaner, you could literally press a button on our website, and it will conjure up through your browser that particular vacuum as a hologram. You can pinch it, zoom it, rotate it, put it in your closet and take a selfie to send to your partner and say, ‘That’s the one we want to buy.’ AR is very useful in converting online shoppers into buyers.”

Stock2Me’s latest podcast features Staci Wallace, leading expert in the fields of business psychology and process strategy. Wallace helps business owners, leaders and entrepreneurs learn essential hacks to build a life and a business they love. For over 30 years in corporate America, she has been effectively shifting mindsets into greater outcomes as an engaging speaker, thought leader, business executive and author of eight books, including her latest, Fueled by Fire, now available on Amazon. She is also host of the Comeback Small Business Radio Show and holds a black belt in mixed martial arts.

Stock2Me’s latest podcast features Staci Wallace, leading expert in the fields of business psychology and process strategy. Wallace helps business owners, leaders and entrepreneurs learn essential hacks to build a life and a business they love. For over 30 years in corporate America, she has been effectively shifting mindsets into greater outcomes as an engaging speaker, thought leader, business executive and author of eight books, including her latest, Fueled by Fire, now available on Amazon. She is also host of the Comeback Small Business Radio Show and holds a black belt in mixed martial arts.

Stock2Me’s latest podcast features Lomit Patel, expert in AI and early-stage business growth. Patel is Vice President of Growth at IMVU. He previously managed growth at startups including Roku; TrustedID, which was acquired by Equifax; Texture, which was acquired by Apple; and EarthLink. Patel is a public speaker, author and advisor, and he is recognized as a Mobile Hero by Liftoff. His new bestselling book “Lean AI: How Innovative Startups Use Artificial Intelligence to Grow” is part of Eric Ries’ “The Lean Startup” series, now available on Amazon.

Stock2Me’s latest podcast features Lomit Patel, expert in AI and early-stage business growth. Patel is Vice President of Growth at IMVU. He previously managed growth at startups including Roku; TrustedID, which was acquired by Equifax; Texture, which was acquired by Apple; and EarthLink. Patel is a public speaker, author and advisor, and he is recognized as a Mobile Hero by Liftoff. His new bestselling book “Lean AI: How Innovative Startups Use Artificial Intelligence to Grow” is part of Eric Ries’ “The Lean Startup” series, now available on Amazon.

The Stock2Me Podcast features a fascinating array of companies and individuals, many of whom are actively revolutionizing age-old business practices within their respective markets. Stock2Me’s latest podcast features Ian Rosen, fintech and financial media expert. Rosen is former CEO of StockTwits.com, co-founder of Even Financial and former general manager of MarketWatch.

Throughout the interview, Rosen discussed business model changes that media companies must make in order to ensure their success going forward. 

The Stock2Me Podcast features a fascinating array of companies and individuals, many of whom are actively revolutionizing age-old business practices within their respective markets. Stock2Me’s latest podcast features Ian Rosen, fintech and financial media expert. Rosen is former CEO of StockTwits.com, co-founder of Even Financial and former general manager of MarketWatch.

Throughout the interview, Rosen discussed business model changes that media companies must make in order to ensure their success going forward. 

The Stock2Me Podcast features a fascinating array of companies and individuals, many of whom are actively revolutionizing age-old business practices within their respective markets. Stock2Me’s latest podcast features James Sapirstein, President & CEO of AzurRx BioPharma Inc. (NASDAQ: AZRX).

AzurRx currently has two ongoing clinical trials for MS1819. The first is a Phase 2 Cystic Fibrosis Combination Trial examining MS1819 in combination with PERT, which is expected to produce topline data in Q2 2021.

The Stock2Me Podcast features a fascinating array of companies and individuals, many of whom are actively revolutionizing age-old business practices within their respective markets. Stock2Me’s latest podcast features James Sapirstein, President & CEO of AzurRx BioPharma Inc. (NASDAQ: AZRX).

AzurRx currently has two ongoing clinical trials for MS1819. The first is a Phase 2 Cystic Fibrosis Combination Trial examining MS1819 in combination with PERT, which is expected to produce topline data in Q2 2021.

Stock2Me’s latest podcast features John Truman Wolfe, number one best-selling and international award-winning author of The Coming Financial Crisis: A Look Behind the Wizard's Curtain and The 99 Strongest Banks in America. Wolfe is also the editor and publisher of Strategic Financial Intelligence, a monthly newsletter dealing with investing, politics and the economy.

Stock2Me’s latest podcast features John Truman Wolfe, number one best-selling and international award-winning author of The Coming Financial Crisis: A Look Behind the Wizard's Curtain and The 99 Strongest Banks in America. Wolfe is also the editor and publisher of Strategic Financial Intelligence, a monthly newsletter dealing with investing, politics and the economy.

Stock2Me’s latest podcast features Shawn Singh, CEO of VistaGen Therapeutics Inc. (NASDAQ: VTGN).

“Throughout the many years I’ve been in the [biopharma] space, I really haven’t been satisfied with the treatment alternatives that have been available to people all around the world who are suffering from mental illness, especially anxiety and depression,” Singh stated during the interview. “VistaGen provides, I think, an opportunity for tremendous excitement, given what we’re working on in our pipeline. We have three drug candidates focused on trying to go beyond the current standard of care for anxiety, depression and other CNS, or central nervous system, disorders.”

VistaGen’s lead drug candidate, PH94B, is a first-in-class neuroactive nasal spray that’s currently being developed as an acute treatment for anxiety in adults with Social Anxiety Disorder (SAD). Fast-acting (10-15 minutes), non-systemic and non-sedating in Phase 2 clinical studies, PH94B has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA), positioning it to potentially become the first FDA-approved fast-acting acute treatment for adults with SAD, if planned Phase 3 studies are successful.

Stock2Me’s latest podcast features Shawn Singh, CEO of VistaGen Therapeutics Inc. (NASDAQ: VTGN).

“Throughout the many years I’ve been in the [biopharma] space, I really haven’t been satisfied with the treatment alternatives that have been available to people all around the world who are suffering from mental illness, especially anxiety and depression,” Singh stated during the interview. “VistaGen provides, I think, an opportunity for tremendous excitement, given what we’re working on in our pipeline. We have three drug candidates focused on trying to go beyond the current standard of care for anxiety, depression and other CNS, or central nervous system, disorders.”

VistaGen’s lead drug candidate, PH94B, is a first-in-class neuroactive nasal spray that’s currently being developed as an acute treatment for anxiety in adults with Social Anxiety Disorder (SAD). Fast-acting (10-15 minutes), non-systemic and non-sedating in Phase 2 clinical studies, PH94B has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA), positioning it to potentially become the first FDA-approved fast-acting acute treatment for adults with SAD, if planned Phase 3 studies are successful.